KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Shares Outstanding (2016 - 2025)

West Pharmaceutical Services' Shares Outstanding history spans 16 years, with the latest figure at $75.3 million for Q2 2024.

  • For Q2 2024, Shares Outstanding changed 0.0% year-over-year to $75.3 million; the TTM value through Jun 2024 reached $75.3 million, changed 0.0%, while the annual FY2023 figure was $75.3 million, 0.0% changed from the prior year.
  • Shares Outstanding for Q2 2024 was $75.3 million at West Pharmaceutical Services, roughly flat from $75.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $75.3 million in Q3 2020 and bottomed at $1.2 million in Q3 2021.
  • The 5-year median for Shares Outstanding is $75.3 million (2020), against an average of $55.6 million.
  • The largest YoY upside for Shares Outstanding was 4606.25% in 2020 against a maximum downside of 97.74% in 2020.
  • A 5-year view of Shares Outstanding shows it stood at $75.3 million in 2020, then changed by 0.0% to $75.3 million in 2021, then changed by 0.0% to $75.3 million in 2022, then changed by 0.0% to $75.3 million in 2023, then changed by 0.0% to $75.3 million in 2024.
  • Per Business Quant, the three most recent readings for WST's Shares Outstanding are $75.3 million (Q2 2024), $75.3 million (Q1 2024), and $75.3 million (Q4 2023).